Cenova Capital
Overview
One the earliest healthcare dedicated funds in China, Cenova Capital was established in 2010 to provide thoughtful and connected capital to transform China's healthcare industry. As a value-oriented investor, Cenova uses a methodical, research-based approach to uncover unique proprietary investment opportunities, and build synergies across its portfolio. Cenova has four funds under management with a combined AUM of over USD600 million invested in over 40 companies in the life sciences and healthcare product and services sectors, including directly or indirectly more than 30 hospitals in Mainland China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Accro Bioscience | May 2026 | Series C | Co-investor |
| Shanghai Apactron Particle Equipment Co., Ltd. | Jan 2026 | Series B | - |
| Vivace Therapeutics | Mar 2025 | Series D | Co-investor |
| Weimai | Jan 2025 | Series D | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cenova Capital based?
Cenova Capital is headquartered in Shanghai, Shanghai, China.
When was Cenova Capital founded?
Cenova Capital was founded in 2010.
How many portfolio companies does Cenova Capital have?
Cenova Capital has 28 portfolio companies in Caplight's dataset.
What are some companies in Cenova Capital's portfolio?
Recent investments visible on Caplight include Accro Bioscience Inc., Accro Bioscience, Shanghai Apactron Particle Equipment Co., Ltd., Vivace Therapeutics, Weimai.
What was Cenova Capital's most recent investment?
Cenova Capital's most recent investment on Caplight was in Accro Bioscience Inc. in 2026.
What sectors does Cenova Capital focus on?
Cenova Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Cenova Capital focus on?
Cenova Capital typically invests at the MultiStage stage.
What is Cenova Capital's AUM?
Cenova Capital's assets under management are estimated between $500.0M and $1.0B.